These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12642014)

  • 1. Role of endothelin-1 in hypertension.
    Iglarz M; Schiffrin EL
    Curr Hypertens Rep; 2003 Apr; 5(2):144-8. PubMed ID: 12642014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin and endothelin antagonists in hypertension.
    Schiffrin EL
    J Hypertens; 1998 Dec; 16(12 Pt 2):1891-5. PubMed ID: 9886874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-of-the-Art lecture. Role of endothelin-1 in hypertension.
    Schiffrin EL
    Hypertension; 1999 Oct; 34(4 Pt 2):876-81. PubMed ID: 10523377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin: role in hypertension.
    Schiffrin EL
    Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelin-1 in hypertension and vascular disease.
    Schiffrin EL
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):83S-89S. PubMed ID: 11411770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
    Watts SW; Fink GD; Northcott CA; Galligan JJ
    Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension.
    Barton M; d'Uscio LV; Shaw S; Meyer P; Moreau P; Lüscher TF
    Hypertension; 1998 Jan; 31(1 Pt 2):499-504. PubMed ID: 9453352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
    Johnson RJ; Galligan JJ; Fink GD
    J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
    Johnson RJ; Fink GD; Watts SW; Galligan JJ
    J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension.
    Iglarz M; Touyz RM; Amiri F; Lavoie MF; Diep QN; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):45-51. PubMed ID: 12524223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical properties of mesenteric resistance arteries from Dahl salt-resistant and salt-sensitive rats: role of endothelin-1.
    Intengan HD; Schiffrin EL
    J Hypertens; 1998 Dec; 16(12 Pt 2):1907-12. PubMed ID: 9886876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
    Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
    J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin in hypertension.
    Schiffrin EL
    Curr Opin Cardiol; 1995 Sep; 10(5):485-94. PubMed ID: 7496057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of endothelin-1 in human hypertension.
    Shreenivas S; Oparil S
    Clin Hemorheol Microcirc; 2007; 37(1-2):157-78. PubMed ID: 17641406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin: role in experimental hypertension.
    Schiffrin EL
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S33-35. PubMed ID: 10976778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin in atherosclerosis: importance of risk factors and therapeutic implications.
    d'Uscio LV; Barton M; Shaw S; Lüscher TF
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S55-59. PubMed ID: 10976783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade.
    d'Uscio LV; Barton M; Shaw S; Moreau P; Lüscher TF
    Hypertension; 1997 Oct; 30(4):905-11. PubMed ID: 9336391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
    Li JS; Larivière R; Schiffrin EL
    Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.